Article: Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: Correlation with FDG-PET/CT

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleQuantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: Correlation with FDG-PET/CT
AuthorsGu, J3
Khong, PL3
Wang, S3
Chan, Q1
Law, W3
Zhang, J2 3
KeywordsADC
DWI
PET/CT
Primary rectal adenocarcinoma
SUV
TDI
TLG
Issue Date2011
PublisherSpringer New York LLC.
CitationMolecular Imaging And Biology, 2011, v. 13 n. 5, p. 1020-1028 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s11307-010-0433-7
AbstractPurpose: The aim of the study was to assess correlations between parameters on diffusionweighted imaging and 2-deoxy-2-[ 18F]fluoro-D-glucose- positron emission tomography/computed tomography (FDG-PET/CT) in rectal cancer. Procedures: Thirty-three consecutive patients with pathologically confirmed rectal adenocarcinoma were included in this study. Apparent diffusion coefficient (ADC) maps were generated to calculate ADC mean (average ADC), ADC min (lowest ADC), tumor volume, and total diffusivity index (TDI). PET/CT exams were performed within 1 week of magnetic resonance imaging. Standardized uptake values (SUVs) were normalized to the injected FDG dose and body weight. SUV max (maximum SUV), SUV mean (average SUV), tumor volume, and total lesion glycolysis (TLG) were calculated using a 50% threshold. Results: Significant negative correlations were found between ADC min and SUV max (r=-0.450, p=0.009), and between ADC mean and SUV mean (r=-0.402, p=0.020). A significant positive correlation was found between TDI and TLG (r=0.634, p<0.001). Conclusion: The significant negative correlations between ADC and SUV suggest an association between tumor cellularity and metabolic activity in primary rectal adenocarcinoma. © Academy of Molecular Imaging and Society for Molecular Imaging, 2010.
ISSN1536-1632
2011 Impact Factor: 3.844
2011 SCImago Journal Rankings: 0.313
DOIhttp://dx.doi.org/10.1007/s11307-010-0433-7
ISI Accession Number IDWOS:000295176200023
PubMed Central IDPMC3179585
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorGu, J
dc.contributor.authorKhong, PL
dc.contributor.authorWang, S
dc.contributor.authorChan, Q
dc.contributor.authorLaw, W
dc.contributor.authorZhang, J
dc.date.accessioned2012-02-21T05:44:46Z
dc.date.available2012-02-21T05:44:46Z
dc.date.issued2011
dc.description.abstractPurpose: The aim of the study was to assess correlations between parameters on diffusionweighted imaging and 2-deoxy-2-[ 18F]fluoro-D-glucose- positron emission tomography/computed tomography (FDG-PET/CT) in rectal cancer. Procedures: Thirty-three consecutive patients with pathologically confirmed rectal adenocarcinoma were included in this study. Apparent diffusion coefficient (ADC) maps were generated to calculate ADC mean (average ADC), ADC min (lowest ADC), tumor volume, and total diffusivity index (TDI). PET/CT exams were performed within 1 week of magnetic resonance imaging. Standardized uptake values (SUVs) were normalized to the injected FDG dose and body weight. SUV max (maximum SUV), SUV mean (average SUV), tumor volume, and total lesion glycolysis (TLG) were calculated using a 50% threshold. Results: Significant negative correlations were found between ADC min and SUV max (r=-0.450, p=0.009), and between ADC mean and SUV mean (r=-0.402, p=0.020). A significant positive correlation was found between TDI and TLG (r=0.634, p<0.001). Conclusion: The significant negative correlations between ADC and SUV suggest an association between tumor cellularity and metabolic activity in primary rectal adenocarcinoma. © Academy of Molecular Imaging and Society for Molecular Imaging, 2010.
dc.description.naturepublished_or_final_version
dc.description.otherSpringer Open Choice, 21 Feb 2012
dc.identifier.citationMolecular Imaging And Biology, 2011, v. 13 n. 5, p. 1020-1028 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s11307-010-0433-7
dc.identifier.citeulike7929003
dc.identifier.doihttp://dx.doi.org/10.1007/s11307-010-0433-7
dc.identifier.eissn1860-2002
dc.identifier.epage1028
dc.identifier.hkuros192107
dc.identifier.isiWOS:000295176200023
dc.identifier.issn1536-1632
2011 Impact Factor: 3.844
2011 SCImago Journal Rankings: 0.313
dc.identifier.issue5
dc.identifier.pmcidPMC3179585
dc.identifier.pmid20872077
dc.identifier.scopuseid_2-s2.0-84855688291
dc.identifier.spage1020
dc.identifier.urihttp://hdl.handle.net/10722/145099
dc.identifier.volume13
dc.languageeng
dc.publisherSpringer New York LLC.
dc.publisher.placeUnited States
dc.relation.ispartofMolecular Imaging and Biology
dc.relation.referencesReferences in Scopus
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.rightsThe Author(s)
dc.rightsThe original publication is available at www.springerlink.com
dc.subject.meshFluorodeoxyglucose F18 - diagnostic use
dc.subject.meshMagnetic Resonance Imaging - methods
dc.subject.meshHumans
dc.subject.meshPositron-Emission Tomography and Computed Tomography - methods
dc.subject.meshRectal Neoplasms - diagnosis - pathology
dc.subjectADC
dc.subjectDWI
dc.subjectPET/CT
dc.subjectPrimary rectal adenocarcinoma
dc.subjectSUV
dc.subjectTDI
dc.subjectTLG
dc.titleQuantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: Correlation with FDG-PET/CT
dc.typeArticle
Author Affiliations
  1. Philips Electronics Hong Kong Limited
  2. Memorial Sloan-Kettering Cancer Center
  3. The University of Hong Kong